Sfoglia per Rivista
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
2011-01-01 Omar, Ha; Chou, Cc; Berman-Booty, Ld; Ma, Y; Hung, Jh; Wang, D; Kogure, T; Patel, T; Terracciano, L; Muthusamy, N; Byrd, Jc; Kulp, Sk; Chen, Cs
Apotopes and the biliary specificity of primary biliary cirrhosis
2009-01-01 Lleo De Nalda, A.; Selmi, C.; Invernizzi, P.; Podda, M.; Coppel, R. L.; Mackay, I. R.; Gores, G. J.; Ansari, A. A.; Van de Water, J.; Gershwin, M. E.
B cell depletion therapy exacerbates murine primary biliary cirrhosis
2011-01-01 Dhirapong, A; Lleo, A; Yang, G-X; Tsuneyama, K; Dunn, R; Kehry, M; Packard, Ta; Cambier, Jc; Liu, Ft; Lindor, K; Coppel, Rl; (co-first author), Ansari AA and Gershwin ME.
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury
2018-01-01 Faggioli, F.; Palagano, E.; Di Tommaso, L.; Donadon, M.; Marrella, V.; Recordati, C.; Mantero, S.; Villa, A.; Vezzoni, P.; Cassani, B.
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis
2010-01-01 Lleo, A; Bowlus, Lc; Yang, Qx; Invernizzi, P; Podda, M; Van de Water, J; Ansari, Aa; Coppel, Rl; Worman, Hj; Gores GJ and Gershwin ME,
Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells
2008-01-01 Shimoda, S.; Harada, K.; Niiro, H.; Yoshizumi, T.; Soejima, Y.; Taketomi, A.; Maehara, Y.; Tsuneyama, K.; Nakamura, M.; Komori, A.; Migita, K.; Nakanuma, Y.; Ishibashi, H.; Selmi, C.; Gershwin, M. E.
Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure
2013-01-01 Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy
2017-01-01 Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
2018-01-01 Brunt, E; Aishima, S; Clavien, Pa; Fowler, K; Goodman, Z; Gores, G; Gouw, A; Kagen, A; Klimstra, D; Komuta, M; Kondo, F; Miksad, R; Nakano, M; Nakanuma, Y; Ng, I; Paradis, V; Park, Yn; Quaglia, A; Roncalli, M; Roskams, T; Sakamoto, M; Saxena, R; Sempoux, C; Sirlin, C; Stueck, A; Thung, S; Tsui, Wms; Wang, Xw; Wee, A; Yano, H; Yeh, M; Zen, Y; Zucman-Rossi, J; Theise, N
CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
2019-01-01 Sangro, B; Hsu, C; Kang, Yk; Kim, Ty; El-Khoueiry, A; Santoro, A; Melero, I; Kudo, M; Hou, Mm; Pena, Am; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, B; Acosta, Mr; Lim, Hy; Neely, J; Zhao, Hy; Anderson, J; Yau, T
Cholangiocarcinoma Stem-like Subset Shapes Tumor-initiating Niche by Educating Associated Macrophages
2016-01-01 Raggi, C; Correnti, M; Sica, A; Andersen, Jb; Cardinale, V; Alvaro, D; Chiorino, G; Forti, E; Glaser, Ss; Alpini, G; Destro, A; Sozio, F; Di Tommaso, L; Roncalli, M; Banales, J; Coulouarn, C; Bujanda, L; Torzilli, G; Invernizzi, P
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
2010-01-01 Bellecave, P; Sarasin-Filipowicz, M; Donzé, O; Kennel, A; Gouttenoire, J; Mey-lan, E; Terracciano, L; Tschopp, J; Sarrazin, C; Berg, T; Moradpour, D; Heim, Mh
Comparative analysis of portal cell infiltrates in AMA positive versus AMA negative PBC
2012-01-01 Jin, Q; Moritoki, Y; Lleo, A; Tsuneyama, K; Invernizzi, P; Moritoki, H; Kikuchi, K; Lian, Zx; Hirschfield, Gm; Ansari, Aa; Coppel, Rl; Gershwin, Me; Niu, J.
Comprehensive allelotype study of hepatocellular carcinoma
2000-01-01 Roncalli, M; Borzio, M; Bianchi, P; Laghi, L.
Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis
2001-01-01 Fracanzani, Al; Burdick, L; Borzio, M; Roncalli, M; Bonelli, N; Borzio, F; Maraschi, A; Fiorelli, G; Fargion, S.
COPY NUMBER VARIATION DIFFERENCES IN MONOZYGOTIC TWINS DISCORDANT FOR PRIMARY BILIARY CIRRHOSIS
2011-01-01 Cavaciocchi, F; Meda, F; Cheroni, C; De Francesco, R; Lleo, A; Lombardi, Sa; De Santis, M; Zammataro, L; Mayo, M; Bach, N; Shimoda, S; Gordon, Sc; Invernizzi, P; Podda, M; Gershwin, Me; Selmi, C
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis
2006-01-01 WESIERSKA-GADEK, J.; Penner, E.; Battezzati, P. M.; Selmi, C.; Zuin, M.; Hitchman, E.; Worman, H. J.; Gershwin, M. E.; Podda, M.; Invernizzi, P.
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
2019-01-01 Mantovani, S; Oliviero, B; Lombardi, A; Varchetta, S; Mele, D; Sangiovanni, A; Rossi, G; Donadon, M; Torzilli, G; Soldani, C; Porta, C; Pedrazzoli, P; Chiellino, S; Santambrogio, R; Opocher, E; Maestri, M; Bernuzzi, S; Rossello, A; Clement, S; De Vito, C; Rubbia-Brandt, L; Negro, F; Mondelli, Mu
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
2016-01-01 Burza, M. A.; Motta, B. M.; Mancina, R. M.; Pingitore, P.; Pirazzi, C.; Lepore, S. M.; Spagnuolo, R.; Doldo, P.; Russo, C.; Lazzaro, V.; Fischer, J.; Berg, T.; Aghemo, A.; Cheroni, C.; De Francesco, R.; Fargion, S.; Colombo, M.; Datz, C.; Stickel, F.; Valenti, L.; Romeo, S.
Deregulation of the immune-related transcriptome in Resected human Biliary Tract Cancers
2016-01-01 Ghidini, M; Cascione, L; Lampis, A; Pandolfo, R; Carotenuto, P; Trevisani, F; Hahne, J; Zito, D; Guzzardo, V; Zerbi, A; Torzilli, G; Roncalli, M; Rimassa, L; Santoro, A; Fassan, M; Valeri, N; Braconi, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. | 1-gen-2011 | Omar, Ha; Chou, Cc; Berman-Booty, Ld; Ma, Y; Hung, Jh; Wang, D; Kogure, T; Patel, T; Terracciano, L; Muthusamy, N; Byrd, Jc; Kulp, Sk; Chen, Cs | |
| Apotopes and the biliary specificity of primary biliary cirrhosis | 1-gen-2009 | Lleo De Nalda, A.; Selmi, C.; Invernizzi, P.; Podda, M.; Coppel, R. L.; Mackay, I. R.; Gores, G. J.; Ansari, A. A.; Van de Water, J.; Gershwin, M. E. | |
| B cell depletion therapy exacerbates murine primary biliary cirrhosis | 1-gen-2011 | Dhirapong, A; Lleo, A; Yang, G-X; Tsuneyama, K; Dunn, R; Kehry, M; Packard, Ta; Cambier, Jc; Liu, Ft; Lindor, K; Coppel, Rl; (co-first author), Ansari AA and Gershwin ME. | |
| B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury | 1-gen-2018 | Faggioli, F.; Palagano, E.; Di Tommaso, L.; Donadon, M.; Marrella, V.; Recordati, C.; Mantero, S.; Villa, A.; Vezzoni, P.; Cassani, B. | |
| Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis | 1-gen-2010 | Lleo, A; Bowlus, Lc; Yang, Qx; Invernizzi, P; Podda, M; Van de Water, J; Ansari, Aa; Coppel, Rl; Worman, Hj; Gores GJ and Gershwin ME, | |
| Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells | 1-gen-2008 | Shimoda, S.; Harada, K.; Niiro, H.; Yoshizumi, T.; Soejima, Y.; Taketomi, A.; Maehara, Y.; Tsuneyama, K.; Nakamura, M.; Komori, A.; Migita, K.; Nakanuma, Y.; Ishibashi, H.; Selmi, C.; Gershwin, M. E. | |
| Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure | 1-gen-2013 | Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf | |
| Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy | 1-gen-2017 | Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F | |
| cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation | 1-gen-2018 | Brunt, E; Aishima, S; Clavien, Pa; Fowler, K; Goodman, Z; Gores, G; Gouw, A; Kagen, A; Klimstra, D; Komuta, M; Kondo, F; Miksad, R; Nakano, M; Nakanuma, Y; Ng, I; Paradis, V; Park, Yn; Quaglia, A; Roncalli, M; Roskams, T; Sakamoto, M; Saxena, R; Sempoux, C; Sirlin, C; Stueck, A; Thung, S; Tsui, Wms; Wang, Xw; Wee, A; Yano, H; Yeh, M; Zen, Y; Zucman-Rossi, J; Theise, N | |
| CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA | 1-gen-2019 | Sangro, B; Hsu, C; Kang, Yk; Kim, Ty; El-Khoueiry, A; Santoro, A; Melero, I; Kudo, M; Hou, Mm; Pena, Am; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, B; Acosta, Mr; Lim, Hy; Neely, J; Zhao, Hy; Anderson, J; Yau, T | |
| Cholangiocarcinoma Stem-like Subset Shapes Tumor-initiating Niche by Educating Associated Macrophages | 1-gen-2016 | Raggi, C; Correnti, M; Sica, A; Andersen, Jb; Cardinale, V; Alvaro, D; Chiorino, G; Forti, E; Glaser, Ss; Alpini, G; Destro, A; Sozio, F; Di Tommaso, L; Roncalli, M; Banales, J; Coulouarn, C; Bujanda, L; Torzilli, G; Invernizzi, P | |
| Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. | 1-gen-2010 | Bellecave, P; Sarasin-Filipowicz, M; Donzé, O; Kennel, A; Gouttenoire, J; Mey-lan, E; Terracciano, L; Tschopp, J; Sarrazin, C; Berg, T; Moradpour, D; Heim, Mh | |
| Comparative analysis of portal cell infiltrates in AMA positive versus AMA negative PBC | 1-gen-2012 | Jin, Q; Moritoki, Y; Lleo, A; Tsuneyama, K; Invernizzi, P; Moritoki, H; Kikuchi, K; Lian, Zx; Hirschfield, Gm; Ansari, Aa; Coppel, Rl; Gershwin, Me; Niu, J. | |
| Comprehensive allelotype study of hepatocellular carcinoma | 1-gen-2000 | Roncalli, M; Borzio, M; Bianchi, P; Laghi, L. | |
| Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis | 1-gen-2001 | Fracanzani, Al; Burdick, L; Borzio, M; Roncalli, M; Bonelli, N; Borzio, F; Maraschi, A; Fiorelli, G; Fargion, S. | |
| COPY NUMBER VARIATION DIFFERENCES IN MONOZYGOTIC TWINS DISCORDANT FOR PRIMARY BILIARY CIRRHOSIS | 1-gen-2011 | Cavaciocchi, F; Meda, F; Cheroni, C; De Francesco, R; Lleo, A; Lombardi, Sa; De Santis, M; Zammataro, L; Mayo, M; Bach, N; Shimoda, S; Gordon, Sc; Invernizzi, P; Podda, M; Gershwin, Me; Selmi, C | |
| Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis | 1-gen-2006 | WESIERSKA-GADEK, J.; Penner, E.; Battezzati, P. M.; Selmi, C.; Zuin, M.; Hitchman, E.; Worman, H. J.; Gershwin, M. E.; Podda, M.; Invernizzi, P. | |
| Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma | 1-gen-2019 | Mantovani, S; Oliviero, B; Lombardi, A; Varchetta, S; Mele, D; Sangiovanni, A; Rossi, G; Donadon, M; Torzilli, G; Soldani, C; Porta, C; Pedrazzoli, P; Chiellino, S; Santambrogio, R; Opocher, E; Maestri, M; Bernuzzi, S; Rossello, A; Clement, S; De Vito, C; Rubbia-Brandt, L; Negro, F; Mondelli, Mu | |
| DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection | 1-gen-2016 | Burza, M. A.; Motta, B. M.; Mancina, R. M.; Pingitore, P.; Pirazzi, C.; Lepore, S. M.; Spagnuolo, R.; Doldo, P.; Russo, C.; Lazzaro, V.; Fischer, J.; Berg, T.; Aghemo, A.; Cheroni, C.; De Francesco, R.; Fargion, S.; Colombo, M.; Datz, C.; Stickel, F.; Valenti, L.; Romeo, S. | |
| Deregulation of the immune-related transcriptome in Resected human Biliary Tract Cancers | 1-gen-2016 | Ghidini, M; Cascione, L; Lampis, A; Pandolfo, R; Carotenuto, P; Trevisani, F; Hahne, J; Zito, D; Guzzardo, V; Zerbi, A; Torzilli, G; Roncalli, M; Rimassa, L; Santoro, A; Fassan, M; Valeri, N; Braconi, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile